DEPOT DRUG

Serial Number 88322740
Registration 6000103
700

Registration Progress

Application Filed
Mar 1, 2019
Under Examination
Approved for Publication
Dec 17, 2019
Published for Opposition
Dec 17, 2019
Registered
Mar 3, 2020

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2020-03-03)
Due: Mar 03, 2026 236 days

Trademark Image

DEPOT DRUG

Basic Information

Serial Number
88322740
Registration Number
6000103
Deadline
March 3, 2026
Description
5 Year - Section 8 and 15 Renewal
Filing Date
March 1, 2019
Registration Date
March 3, 2020
Published for Opposition
December 17, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Mar 3, 2020
Registration
Registered
Classes
035

Rights Holder

Union Pacific Railroad Employes Health Systems

03
Address
1040 North 2200 West, Suite 200
Salt Lake City, UT 84116

Ownership History

Union Pacific Railroad Employes Health Systems

Original Applicant
03
Salt Lake City, UT

Union Pacific Railroad Employes Health Systems

Owner at Publication
03
Salt Lake City, UT

Union Pacific Railroad Employes Health Systems

Original Registrant
03
Salt Lake City, UT

Legal Representation

Attorney
Jonathan W. Richards

USPTO Deadlines

Next Deadline
236 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-03-03)
Due Date
March 03, 2026
Grace Period Ends
September 03, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

26 events
Date Code Type Description
Mar 3, 2025 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 3, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER
Dec 17, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 17, 2019 PUBO A PUBLISHED FOR OPPOSITION
Nov 27, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 14, 2019 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 14, 2019 XAEC I EXAMINER'S AMENDMENT ENTERED
Nov 14, 2019 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 14, 2019 GNEA O EXAMINERS AMENDMENT E-MAILED
Nov 14, 2019 CNEA R EXAMINERS AMENDMENT -WRITTEN
Nov 5, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 5, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 5, 2019 ALIE A ASSIGNED TO LIE
Oct 29, 2019 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Aug 28, 2019 GNSL S LETTER OF SUSPENSION E-MAILED
Aug 28, 2019 CNSL R SUSPENSION LETTER WRITTEN
Aug 28, 2019 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 14, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 13, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 13, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
May 20, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 20, 2019 GNRT F NON-FINAL ACTION E-MAILED
May 20, 2019 CNRT R NON-FINAL ACTION WRITTEN
May 10, 2019 DOCK D ASSIGNED TO EXAMINER
Mar 21, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 5, 2019 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 035
retail pharmacy services; mail order pharmacy services; pharmaceutical services, namely, processing online and telephone prescription orders in retail and central fill pharmacies
First Use Anywhere: Jul 9, 2007
First Use in Commerce: Jul 9, 2007

Classification

International Classes
035

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"DRUG"